https://scholars.lib.ntu.edu.tw/handle/123456789/635002
標題: | Cardiomyopathy Efficacy of Tafamidis in Patients with Ala97Ser Hereditary Transthyretin Cardiac Amyloidosis: A Six-Month Follow-Up Study | 作者: | CHENG-HSUAN TSAI Yu, An-Li Wu, Yuan-Kun Aden MAO-YUAN SU MEI-FANG CHENG Chou, Chia-Hung CHIA-TUNG SHUN HSUEH-WEN HSUEH JYH-MING JIMMY JUANG MING-JEN LEE PING-HUEI TSENG SUNG-TSANG HSIEH CHI-CHAO CHAO YEN-HUNG LIN |
關鍵字: | Cardiomyopathy; Hereditary transthyretin amyloidosis; NT-proBNP; Tafamidis | 公開日期: | 七月-2023 | 卷: | 39 | 期: | 4 | 起(迄)頁: | 619 | 來源出版物: | Acta Cardiologica Sinica | 摘要: | Hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal disease. A97S (p.Ala117Ser) is the most common transthyretin genetic mutation in Taiwan. Tafamidis is a transthyretin stabilizer, and it has been shown to improve outcomes. However, its effect on A97S ATTR-CM subtypes remains unknown. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/635002 | ISSN: | 1011-6842 | DOI: | 10.6515/ACS.202307_39(4).20221116A |
顯示於: | 法醫學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。